RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
Hugo VeyssiereMargot DressaireRaphaël PeteCéleste PinardIoana MolnarCatherine AbrialAngeline GinzacXavier DurandoMarielle TekathPublished in: BMC cancer (2023)
ClinicalTrials.gov ID; NCT04750889 registered on February 11, 2021.